Orthopedic Oncology Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: O8F044BB9A68EN
Market Monitor Global

Abstracts

Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of musculoskeletal system which includes trauma, spine, hand and upper extremity, total joints and even pediatric orthopedics.

This report contains market size and forecasts of Orthopedic Oncology Treatment in Global, including the following market information:

Global Orthopedic Oncology Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Orthopedic Oncology Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Soft Tissue Excisions/Resections Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Orthopedic Oncology Treatment include Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, DePuy Synthes (Johnson & Johnson), Medtronic, Accentus Medical, Roche Holding AG, Amgen, Inc. and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orthopedic Oncology Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Orthopedic Oncology Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Orthopedic Oncology Treatment Market Segment Percentages, by Type, 2021 (%)

• Soft Tissue Excisions/Resections
• Limb Salvage Surgery
• Amputation
• Adjuvant Chemotherapy
• Reconstructive Surgery

Global Orthopedic Oncology Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Orthopedic Oncology Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinic
• Others

Global Orthopedic Oncology Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Orthopedic Oncology Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Orthopedic Oncology Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Orthopedic Oncology Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• DePuy Synthes (Johnson & Johnson)
• Medtronic
• Accentus Medical
• Roche Holding AG
• Amgen, Inc.
• Novartis AG
• GlaxoSmithKline
• Sanofi
• Pfizer Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Orthopedic Oncology Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Orthopedic Oncology Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ORTHOPEDIC ONCOLOGY TREATMENT OVERALL MARKET SIZE

2.1 Global Orthopedic Oncology Treatment Market Size: 2021 VS 2028
2.2 Global Orthopedic Oncology Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Orthopedic Oncology Treatment Players in Global Market
3.2 Top Global Orthopedic Oncology Treatment Companies Ranked by Revenue
3.3 Global Orthopedic Oncology Treatment Revenue by Companies
3.4 Top 3 and Top 5 Orthopedic Oncology Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Orthopedic Oncology Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orthopedic Oncology Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Orthopedic Oncology Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Orthopedic Oncology Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Orthopedic Oncology Treatment Market Size Markets, 2021 & 2028
  4.1.2 Soft Tissue Excisions/Resections
  4.1.3 Limb Salvage Surgery
  4.1.4 Amputation
  4.1.5 Adjuvant Chemotherapy
  4.1.6 Reconstructive Surgery
4.2 By Type - Global Orthopedic Oncology Treatment Revenue & Forecasts
  4.2.1 By Type - Global Orthopedic Oncology Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Orthopedic Oncology Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Orthopedic Oncology Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Orthopedic Oncology Treatment Revenue & Forecasts
  5.2.1 By Application - Global Orthopedic Oncology Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Orthopedic Oncology Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Orthopedic Oncology Treatment Market Size, 2021 & 2028
6.2 By Region - Global Orthopedic Oncology Treatment Revenue & Forecasts
  6.2.1 By Region - Global Orthopedic Oncology Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Orthopedic Oncology Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Orthopedic Oncology Treatment Revenue, 2017-2028
  6.3.2 US Orthopedic Oncology Treatment Market Size, 2017-2028
  6.3.3 Canada Orthopedic Oncology Treatment Market Size, 2017-2028
  6.3.4 Mexico Orthopedic Oncology Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Orthopedic Oncology Treatment Revenue, 2017-2028
  6.4.2 Germany Orthopedic Oncology Treatment Market Size, 2017-2028
  6.4.3 France Orthopedic Oncology Treatment Market Size, 2017-2028
  6.4.4 U.K. Orthopedic Oncology Treatment Market Size, 2017-2028
  6.4.5 Italy Orthopedic Oncology Treatment Market Size, 2017-2028
  6.4.6 Russia Orthopedic Oncology Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Orthopedic Oncology Treatment Market Size, 2017-2028
  6.4.8 Benelux Orthopedic Oncology Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Orthopedic Oncology Treatment Revenue, 2017-2028
  6.5.2 China Orthopedic Oncology Treatment Market Size, 2017-2028
  6.5.3 Japan Orthopedic Oncology Treatment Market Size, 2017-2028
  6.5.4 South Korea Orthopedic Oncology Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Orthopedic Oncology Treatment Market Size, 2017-2028
  6.5.6 India Orthopedic Oncology Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Orthopedic Oncology Treatment Revenue, 2017-2028
  6.6.2 Brazil Orthopedic Oncology Treatment Market Size, 2017-2028
  6.6.3 Argentina Orthopedic Oncology Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Orthopedic Oncology Treatment Revenue, 2017-2028
  6.7.2 Turkey Orthopedic Oncology Treatment Market Size, 2017-2028
  6.7.3 Israel Orthopedic Oncology Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Orthopedic Oncology Treatment Market Size, 2017-2028
  6.7.5 UAE Orthopedic Oncology Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Stryker Corporation
  7.1.1 Stryker Corporation Corporate Summary
  7.1.2 Stryker Corporation Business Overview
  7.1.3 Stryker Corporation Orthopedic Oncology Treatment Major Product Offerings
  7.1.4 Stryker Corporation Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.1.5 Stryker Corporation Key News
7.2 Zimmer Biomet Holdings, Inc.
  7.2.1 Zimmer Biomet Holdings, Inc. Corporate Summary
  7.2.2 Zimmer Biomet Holdings, Inc. Business Overview
  7.2.3 Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Major Product Offerings
  7.2.4 Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.2.5 Zimmer Biomet Holdings, Inc. Key News
7.3 Smith & Nephew plc
  7.3.1 Smith & Nephew plc Corporate Summary
  7.3.2 Smith & Nephew plc Business Overview
  7.3.3 Smith & Nephew plc Orthopedic Oncology Treatment Major Product Offerings
  7.3.4 Smith & Nephew plc Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.3.5 Smith & Nephew plc Key News
7.4 DePuy Synthes (Johnson & Johnson)
  7.4.1 DePuy Synthes (Johnson & Johnson) Corporate Summary
  7.4.2 DePuy Synthes (Johnson & Johnson) Business Overview
  7.4.3 DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Major Product Offerings
  7.4.4 DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.4.5 DePuy Synthes (Johnson & Johnson) Key News
7.5 Medtronic
  7.5.1 Medtronic Corporate Summary
  7.5.2 Medtronic Business Overview
  7.5.3 Medtronic Orthopedic Oncology Treatment Major Product Offerings
  7.5.4 Medtronic Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.5.5 Medtronic Key News
7.6 Accentus Medical
  7.6.1 Accentus Medical Corporate Summary
  7.6.2 Accentus Medical Business Overview
  7.6.3 Accentus Medical Orthopedic Oncology Treatment Major Product Offerings
  7.6.4 Accentus Medical Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.6.5 Accentus Medical Key News
7.7 Roche Holding AG
  7.7.1 Roche Holding AG Corporate Summary
  7.7.2 Roche Holding AG Business Overview
  7.7.3 Roche Holding AG Orthopedic Oncology Treatment Major Product Offerings
  7.7.4 Roche Holding AG Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.7.5 Roche Holding AG Key News
7.8 Amgen, Inc.
  7.8.1 Amgen, Inc. Corporate Summary
  7.8.2 Amgen, Inc. Business Overview
  7.8.3 Amgen, Inc. Orthopedic Oncology Treatment Major Product Offerings
  7.8.4 Amgen, Inc. Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.8.5 Amgen, Inc. Key News
7.9 Novartis AG
  7.9.1 Novartis AG Corporate Summary
  7.9.2 Novartis AG Business Overview
  7.9.3 Novartis AG Orthopedic Oncology Treatment Major Product Offerings
  7.9.4 Novartis AG Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.9.5 Novartis AG Key News
7.10 GlaxoSmithKline
  7.10.1 GlaxoSmithKline Corporate Summary
  7.10.2 GlaxoSmithKline Business Overview
  7.10.3 GlaxoSmithKline Orthopedic Oncology Treatment Major Product Offerings
  7.10.4 GlaxoSmithKline Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.10.5 GlaxoSmithKline Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Business Overview
  7.11.3 Sanofi Orthopedic Oncology Treatment Major Product Offerings
  7.11.4 Sanofi Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.11.5 Sanofi Key News
7.12 Pfizer Inc.
  7.12.1 Pfizer Inc. Corporate Summary
  7.12.2 Pfizer Inc. Business Overview
  7.12.3 Pfizer Inc. Orthopedic Oncology Treatment Major Product Offerings
  7.12.4 Pfizer Inc. Orthopedic Oncology Treatment Revenue in Global Market (2017-2022)
  7.12.5 Pfizer Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Orthopedic Oncology Treatment Market Opportunities & Trends in Global Market
Table 2. Orthopedic Oncology Treatment Market Drivers in Global Market
Table 3. Orthopedic Oncology Treatment Market Restraints in Global Market
Table 4. Key Players of Orthopedic Oncology Treatment in Global Market
Table 5. Top Orthopedic Oncology Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Orthopedic Oncology Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Orthopedic Oncology Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Orthopedic Oncology Treatment Product Type
Table 9. List of Global Tier 1 Orthopedic Oncology Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orthopedic Oncology Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Orthopedic Oncology Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Orthopedic Oncology Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Orthopedic Oncology Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Orthopedic Oncology Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Orthopedic Oncology Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Orthopedic Oncology Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Orthopedic Oncology Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Orthopedic Oncology Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Orthopedic Oncology Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Orthopedic Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Orthopedic Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Orthopedic Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Orthopedic Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Orthopedic Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Stryker Corporation Corporate Summary
Table 31. Stryker Corporation Orthopedic Oncology Treatment Product Offerings
Table 32. Stryker Corporation Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Zimmer Biomet Holdings, Inc. Corporate Summary
Table 34. Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Product Offerings
Table 35. Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Smith & Nephew plc Corporate Summary
Table 37. Smith & Nephew plc Orthopedic Oncology Treatment Product Offerings
Table 38. Smith & Nephew plc Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 39. DePuy Synthes (Johnson & Johnson) Corporate Summary
Table 40. DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Product Offerings
Table 41. DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Medtronic Corporate Summary
Table 43. Medtronic Orthopedic Oncology Treatment Product Offerings
Table 44. Medtronic Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Accentus Medical Corporate Summary
Table 46. Accentus Medical Orthopedic Oncology Treatment Product Offerings
Table 47. Accentus Medical Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Roche Holding AG Corporate Summary
Table 49. Roche Holding AG Orthopedic Oncology Treatment Product Offerings
Table 50. Roche Holding AG Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Amgen, Inc. Corporate Summary
Table 52. Amgen, Inc. Orthopedic Oncology Treatment Product Offerings
Table 53. Amgen, Inc. Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Novartis AG Corporate Summary
Table 55. Novartis AG Orthopedic Oncology Treatment Product Offerings
Table 56. Novartis AG Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Orthopedic Oncology Treatment Product Offerings
Table 59. GlaxoSmithKline Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Orthopedic Oncology Treatment Product Offerings
Table 62. Sanofi Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Pfizer Inc. Corporate Summary
Table 64. Pfizer Inc. Orthopedic Oncology Treatment Product Offerings
Table 65. Pfizer Inc. Orthopedic Oncology Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Orthopedic Oncology Treatment Segment by Type in 2021
Figure 2. Orthopedic Oncology Treatment Segment by Application in 2021
Figure 3. Global Orthopedic Oncology Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Orthopedic Oncology Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Orthopedic Oncology Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Orthopedic Oncology Treatment Revenue in 2021
Figure 8. By Type - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
Figure 12. US Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
Figure 24. China Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Orthopedic Oncology Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Orthopedic Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Stryker Corporation Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Smith & Nephew plc Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medtronic Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Accentus Medical Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Holding AG Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amgen, Inc. Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis AG Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sanofi Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pfizer Inc. Orthopedic Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)